全文获取类型
收费全文 | 7744篇 |
免费 | 587篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 238篇 |
妇产科学 | 235篇 |
基础医学 | 1168篇 |
口腔科学 | 138篇 |
临床医学 | 837篇 |
内科学 | 1567篇 |
皮肤病学 | 207篇 |
神经病学 | 752篇 |
特种医学 | 163篇 |
外科学 | 688篇 |
综合类 | 72篇 |
一般理论 | 9篇 |
预防医学 | 892篇 |
眼科学 | 118篇 |
药学 | 638篇 |
中国医学 | 18篇 |
肿瘤学 | 551篇 |
出版年
2023年 | 81篇 |
2022年 | 67篇 |
2021年 | 272篇 |
2020年 | 191篇 |
2019年 | 263篇 |
2018年 | 290篇 |
2017年 | 186篇 |
2016年 | 242篇 |
2015年 | 265篇 |
2014年 | 332篇 |
2013年 | 417篇 |
2012年 | 679篇 |
2011年 | 684篇 |
2010年 | 396篇 |
2009年 | 310篇 |
2008年 | 530篇 |
2007年 | 512篇 |
2006年 | 500篇 |
2005年 | 446篇 |
2004年 | 372篇 |
2003年 | 355篇 |
2002年 | 318篇 |
2001年 | 32篇 |
2000年 | 29篇 |
1999年 | 34篇 |
1998年 | 53篇 |
1997年 | 42篇 |
1996年 | 22篇 |
1995年 | 37篇 |
1994年 | 30篇 |
1993年 | 19篇 |
1992年 | 18篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 16篇 |
1985年 | 29篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 22篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 8篇 |
1974年 | 8篇 |
1973年 | 12篇 |
1928年 | 13篇 |
排序方式: 共有8367条查询结果,搜索用时 128 毫秒
1.
2.
Pilar Garc a-Pe arrubia Antonio Jos Ruiz-Alcaraz Miriam Ruiz-Ballester Tamara Nadira Ram rez-P vez Mar a Mart nez-Esparza 《World journal of gastroenterology : WJG》2021,27(41):7014-7024
Macrophages are a diverse myeloid cell population involved in innate and adaptive immune responses, embryonic development, wound repair, and regulation of tissue homeostasis. These cells link the innate and adaptive immu nities and are crucial in the development and sustainment of various inflammatory diseases. Macrophages are tissue-resident cells in steady-state conditions; however, they are also recruited from blood monocytes after local pathogen invasion or tissue injury. Peritoneal macrophages vary based on their cell complexity, phenotype, and functional capabilities. These cells regulate inflammation and control bacterial infections in the ascites of decompensated cirrhotic patients. Our recent work reported several phenotypic and functional characteristics of these cells under both healthy and pathological conditions. A direct association between cell size, CD14/CD16 expression, intracellular level of GATA-6, and expression of CD206 and HLA-DR activation/maturation markers, indicate that the large peritoneal macrophage CD14highCD16high subset constitutes the mature phenotype of human resident peritoneal macrophages during homeostasis. Moreover, elevated expression of CD14/CD16 is related to the phagocytic capacity. The novel large CD14highCD16high peritoneal subpopulation is increased in the ascites of cirrhotic patients and is highly sensitive to lipopolysaccharide (LPS)-induced activation, thereby exhibiting features of inflammatory priming. Thus, phosphorylation of ERK1/2, PKB/Akt, and c-Jun is remarkably increased in response to LPS in vitro, whereas that of p38 MAPK is reduced compared with the monocyte-derived macrophages from the blood of healthy controls. Furthermore, in vitro activated monocyte-derived macrophages from ascites of cirrhotic patients secreted significantly higher levels of IL-6, IL-10, and TNF-α and lower amounts of IL-1β and IL-12 than the corresponding cells from healthy donor’s blood. Based on these results, other authors have recently reported that the surface expression level of CD206 can be used to identify mature, resident, inflammatory peritoneal macrophages in patients with cirrhosis. Soluble CD206 is released from activated large peritoneal macrophages, and increased concentrations in patients with cirrhosis and spontaneous bacterial peritonitis (SBP) indicate reduced odds of survival for 90 d. Hence, the level of soluble CD206 in ascites might be used to identify patients with SBP at risk of death. In conclusion, peritoneal macrophages present in ascites of cirrhotic patients display multiple phenotypic modifications characterized by reduced ratio of cells expressing several membrane markers, together with an increase in the ratios of complex and intermediate subpopulations and a decrease in the classic-like subset. These modifications may lead to the identification of novel pharmaceutical targets for prevention and treatment of hepatic damage. 相似文献
3.
Dave E. W. van der Kruijssen Auke J. S. van der Kuil Geraldine R. Vink Cornelis J. A. Punt Johannes H. W. de Wilt Sjoerd G. Elias Miriam Koopman 《International journal of cancer. Journal international du cancer》2023,152(7):1360-1369
We studied the prognostic value of primary tumor sidedness in metastatic colorectal cancer over time and across treatment lines. Population data on synchronous metastatic colorectal cancer patients were extracted from the Netherlands Cancer Registry and SEER database. Pubmed, EMBASE and Cochrane library were searched for prospective studies on metastatic colorectal cancer to conduct a meta-analysis. Inclusion criteria consisted of metastatic disease, systemic treatment with palliative intent and specification of primary tumor location. Data were pooled using a random-effects model. For the population-based data, multivariable Cox models were constructed. The Grambsch-Therneau test was conducted to evaluate the potential time-varying nature of sidedness. Meta-regression incorporating treatment-line as variable was conducted to test the pre-specified hypothesis that the prognostic value of sidedness varies over time. Analysis of 12 885 and 16 160 synchronous metastatic colorectal cancer patients registered in the Netherlands Cancer Registry and SEER database, respectively, indicated a time-varying prognostic value of sidedness (P < .01). Thirty-one studies were selected for the meta-analysis (9558 patients for overall survival analysis). Pooled univariable hazard ratioleft-sided/right-sided for overall survival was 0.71 (95% CI: 0.65-0.76) in 1st-line, 0.76 (0.54-1.06) in 2nd-line and 1.01 (0.86-1.19) in 3rd-line studies. Hazard ratios were significantly influenced by treatment line (P = .035). The prognostic value of sidedness of the primary tumor in metastatic colorectal cancer patients treated with palliative systemic therapy decreases over time since diagnosis, suggesting that sidedness may not be a useful stratification factor in late-line trials. This decrease in prognostic value should be taken into account when providing prognostic information to patients. 相似文献
4.
Wessel Theda Heuing Katharina Schlangen Miriam Schnieders Birgit Algermissen Markus 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(11):1119-1125
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Menschen mit Seltenen Erkrankungen stehen im Gesundheitssystem vor besonderen Herausforderungen. Die Seltenheit der einzelnen... 相似文献
5.
6.
7.
8.
Judith Brock Andreas Schmid Thomas Karrasch Petra Pfefferle Jutta Schlegel Inga Busse Annette Hauenschild Barbara Schmidt Maria Koukou Efthymia Arapogianni Andreas Schultz Miriam Thomalla Secil Akinci Johannes Kruse Winfried Padberg Andreas Schffler Jens Albrecht 《Clinical endocrinology》2019,91(3):400-410
9.